AstraZeneca To Partner With Gene Pioneer Venter To Incorporate Genomics In Drug Research And Development

AstraZeneca will work with biotechnologist Craig Venter and other companies to incorporate genomics in drug research and development. The bold move is aimed at searching for new medicines that uses the advanced technology of genome sequencing.